Cerebral Therapeutics Company Profile: Valuation & Investors?

Cerebral Therapeutics Company Profile: Valuation & Investors?

WebMar 24, 2024 · 11 brokerages have issued twelve-month price objectives for Cerevel Therapeutics' stock. Their CERE share price forecasts range from $22.00 to $46.00. On average, they predict the company's stock price to reach $34.50 in the next twelve months. This suggests a possible upside of 47.5% from the stock's current price. WebJan 25, 2024 · Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment of MedTech industry veteran Julie Foster as Chief Operating Officer. ... Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to … 40/30 blood pressure WebCerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The Company utilizes long-term implanted brain drug-device combination therapies to deliver optimal doses of specially formulated anti-seizure ... WebCerebral Therapeutics Names Julie Foster as Chief Operating Officer. Jan 25, 2024. Jan 25, 2024. Jun 28, 2024. Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing. Jun 28, 2024. Jun 28, 2024. Aug 3, 2024. Cerebral Therapeutics, Inc. Names Guy Anthony as Chief Financial Officer. best free movie watching app for android WebAURORA, Colo.--(BUSINESS WIRE)--Cerebral Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative treatments for neurological diseases, has appointed Stephen J. Farr, PhD as Chairman of the board of directors.Dr. Farr is the Co-Founder, President, and Chief Executive Officer of Zogenix, a biopharmaceutical … WebCerebral's latest funding round was a Series C for $300M on December 8, 2024. Cerebral's valuation in June 2024 was $1,230M. ... Twill provides digital therapeutics and care … 4030 camino andres rd bay point ca Web1 day ago · Based on TYPE, the Brain Tumor Diagnosis and Therapeutics Market from 2024 to 2028 is primarily split into: MRI CT Scan Tissue Sampling PET-CT Scan Cerebral Arteriogram Lumbar Puncture Molecular ...

Post Opinion